Navigation Links
Rock concert aids cancer research
Date:1/18/2011

Rock legends The Who performed alongside Jeff Beck, Blondie singer Debbie Harry and The Verve's Richard Ashcroft. They wowed a packed house and glittering list of celebrities to raise funds for PDT.

The work carried out by Dr. Alison Curnow and her team at the Peninsula Medical School and Royal Cornwall Hospital in Truro, UK, was given an immediate grant from the Killing Cancer charity of 30,000, which came from the proceeds of the concert.

Dr. Curnow commented: "The Peninsula Medical School PDT research team and the very busy dermatology PDT service led by Dr. Sandra Campbell at the Royal Cornwall Hospital are delighted with the generous support provided by Killing Cancer. It was a fantastic show and this funding will enable us to continue our clinical PDT research for another year. PDT is still a relatively little know light-activated anti-cancer drug therapy that can be used topically to destroy certain types of skin cancer without scarring."

David Longman, director of Killing Cancer, added: "Alison's team is doing amazing work in Cornwall. The concert was a great success and it was good to be able to make an immediate grant to recognise quickly the way Alison and her team are developing the use of PDT. The charity and the rock legends who supported us wanted to recognise the incredible research work, dedication and determination of Alison and her team."


'/>"/>

Contact: Andrew Gould
andrew.gould@pcmd.ac.uk
44-139-268-6107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Page: 1

Related medicine news :

1. dbMaestro Achieves “Ready For IBM Rational Software” Validation For Rational Team Concert Integration
2. Hospitals and Health Systems Have a New Solution for Zero Footprint Image Exchange; Orion Health Announces Concerto Enterprise Image Viewer
3. U-M researchers find indirect path to attack breast cancer stem cells
4. Oncology basic research director at John Theurer Cancer Center continues transplantation research
5. Scientists bring cancer cells back under control
6. Scientists identify avoidable breast cancer risk factors
7. Clinicians cite time, patient embarrassment as barriers to performing skin cancer exams
8. Thorough Exams a Must for Those at High Risk of Skin Cancer
9. Breast Cancer Radiation Before 1984 Tied to Heart Disease
10. Study Finds Racial Disparity in Breast Cancer Outcomes
11. Study provides molecular rationale for combining targeted agents to treat breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... 2017 , ... Driving Dynamics Inc., announced today it has been selected as ... part of its mission to continually monitor the training marketplace for the best providers ... 20 Health and Safety Training Companies list was based on the following criteria: , ...
(Date:9/19/2017)... ... September 19, 2017 , ... The ISO 9001 standard ... businesses and organizations become more efficient and improve customer satisfaction. ISO 9001:2015 was released ... own QMS, with a deadline of September 2018. , As described in ...
(Date:9/19/2017)... ... September 19, 2017 , ... Bone ... launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone void filler is ... the U.S. to incorporate magnesium, a critical property for bone health and development. ...
(Date:9/19/2017)... ... , ... First Choice Emergency Room , the largest network of independent ... Medical Director of its Pflugerville- FM 685 facility. , “We are pleased to ... 685 location,” said Dr. Stephen Van Roekel, Reginal Medical Officer of First Choice Emergency ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... the country with the Davidson Fellows Scholarship on September 27 at a reception ... in Science, Technology, Engineering, Mathematics, Literature and Music. , “I am honored to ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... Sept. 6, 2017   PDI , a leader in ... host an educational session focused on the role of ... prevention at the 2017 Annual Scientific Meeting of the ... place at the Phoenix Convention ... Sept. 16-19, will also feature PDI,s Prevantics® Device ...
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
(Date:9/5/2017)... NEWTOWN, Pa. , Sept. 5, 2017  Xyntek Inc. has announced another ... opened a new Midwest office to meet the growing demands of customer engagements ... Xyntek's new Midwest office is located at ... ... demands of customer engagements regionally. ...
Breaking Medicine Technology: